The case for entrepreneurship in R

@RepKatiePorter @JulieBorowski @kevinnbass @DaveDomina @JebKeiper @FiercePharma @pharminews @robertkaaatz @PharmaFactz @pharmalot @MychalWilsonEsq @ekalpas @MrHealthnut @julia_lurie @DarleneMart1 @pharmagossip @TwiceCircled @MudkipizAwesome @GhostManagedM…

@lesamitchell @KauffmanFDN @NatRevDrugDisc @eperlste Yamada, Ringrose, Sato and Douglas identified two discovery types-‘mavericks’ and ‘true believers’. #Mavericks are those scientists who seem to achieve superior results by thinking and working outside…

@lesamitchell @KauffmanFDN @NatRevDrugDisc @eperlste Corr thinks that the optimal group number is closer to 20-40 individuals. He discovered that very small teams allowed for the rapid sharing of information and resource allocation, as well as the effic…

@lesamitchell @KauffmanFDN @NatRevDrugDisc @eperlste Peter Corr supports Andreas Busch’s less entrepreneurial compound progression approach, especially when there are “more shots on goal”. However, Corey Goodman thinks that in many pharmaceutical companie…